StockWatch
·

Bharat Parenterals Ltd Q3 FY26 Results

BPLPHARMAQ3 FY26 Results
Filing
MetricValue ( Cr)Q2 FY26Q3 FY25
Revenue65.190.9%9.8%
Total Income66.522.4%11.6%
Expenditure74.800.9%7.3%
PBT-8.2813.2%50.6%
Net Profit-9.6712.3%22.9%
OPM2.67%1.40pp31.10pp
NPM-14.54%1.91pp4.08pp
EPS14.030.2%240.3%
View full financials

Informational and educational content only. Not investment advice.